The Burden of Fungal Infections in Ethiopia
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The burden of severe fungal infections (FIs) is not well addressed in Ethiopia. We have estimated the burden of FIs from multiple demographic sources and by searching articles from PubMed. Opportunistic FIs were estimated using modelling and 2017 national HIV data. The burdens of chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) were estimated by using the prevalence of asthma, chronic obstructive pulmonary disease, and annual the incidence of tuberculosis. Of the 105,000,000 estimated Ethiopian population, 610,000 are thought to have HIV infection. Our estimation of HIV-related FIs were: 9900 cryptococcal meningitis (CM), 12,700 Pneumocystis jirovecii pneumonia (PCP), 76,300 oral and 56,000 oesophageal candidiasis cases. A remarkable 7,051,700 4–14-year-olds probably have tinea capitis and 1,469,000 women probably have recurrent Candida vaginitis. There were 15,200 estimated CPA cases (prevalence) and 11,500 invasive aspergillosis (IA) cases (incidence). Data are scant, but we estimated 5300 candidaemia and 800 Candida peritonitis cases. In conclusion, approximately 8% of Ethiopians suffer from FIs annually, mostly schoolchildren with tinea capitis. IA, CM and PCP are the major causes of fungal deaths. The absence of CD4 count is challenging the identification of HIV patients at risk of opportunistic FIs. There is a pressing need to improve FI diagnosis, probably including national surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953 · cited 4×
“Robust estimates of fungal disease incidence and prevalence are lacking in Ethiopia [2].”
BackgroundResultInfluentialSelf-citationGlobal burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861 · cited 16×
“The case fatality rate of PCP ranges from 16% to 68% in Africa [45].”
BackgroundInfluentialSelf-citationGlobal asthma prevalence in adults: findings from the cross-sectional world health survey
To, T., Stanojevic, S., Moores, G., Gershon, A. S., Bateman, E. D., Cruz, A. A., & Boulet, L.-P. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-204 · Cited by 1,521
Global burden of recurrent vulvovaginal candidiasis: a systematic review
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30103-8 · Cited by 639
Self-citationDenning, D. W., Pleuvry, A., & Cole, D. C. (2013) · Medical Mycology · doi:10.3109/13693786.2012.738312 · Cited by 495 · cited 7×
“Denning et al. (2013) reported that the annual CPA fatality rate ranges from 10% to 30% [34] and we calculated that CPA is responsible for”
BackgroundInfluentialSelf-citationEpidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03548.x · Cited by 331
Wisplinghoff, H., Ebbers, J., Geurtz, L., Stefanik, D., Major, Y., Edmond, M. B., Wenzel, R. P., & Seifert, H. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.005 · Cited by 293 · cited 1×
“Candidaemia is a leading cause of nosocomial bloodstream infection across the world [79].”
BackgroundFoxman, B., Muraglia, R., Dietz, J.-P., Sobel, J. D., & Wagner, J. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318273e8cf · Cited by 261 · cited 1×
“Recurrent attacks of vulvovaginal candidiasis have been estimated to affect 5–10% of women annually [58,59], primarily based on data from Foxman et al [36,37] (Table 2).”
BackgroundPage, I. D., Richardson, M. D., & Denning, D. W. (2016) · Journal of Infection · doi:10.1016/j.jinf.2015.11.003 · Cited by 161
Self-citationCase Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings
Denning, D. W., Page, I. D., Chakaya, J., Jabeen, K., Jude, C. M., Cornet, M., Alastruey-Izquierdo, A., Bongomin, F., Bowyer, P., Chakrabarti, A., et al. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2408.171312 · Cited by 144
Self-citationDenning, D. W. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0468 · Cited by 117 · cited 2×
“If left untreated, all cryptococcal antigenaemia patients will develop CM [44].”
BackgroundSelf-citationEpidemiology of human dermatophytoses in Africa
Coulibaly, O., L’Ollivier, C., Piarroux, R., & Ranque, S. (2018) · Medical Mycology · doi:10.1093/mmy/myx048 · Cited by 108
Yan, X., Li, M., Jiang, M., Zou, L., Luo, F., & Jiang, Y. (2009) · Cancer · doi:10.1002/cncr.24559 · Cited by 94 · cited 1×
“6% of lung cancer patients will develop IA [56] and that 4% of AIDS deaths are attributable to IA [44].”
BackgroundLoyse, A., Burry, J., Cohn, J., Ford, N., Chiller, T., Ribeiro, I., Koulla-Shiro, S., Mghamba, J., Ramadhani, A., Nyirenda, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30493-6 · Cited by 90 · cited 1×
“Diagnosis and management of these opportunistic mycosis in RLSs is challenging as standard diagnostic methods and essential antifungal medicines are often absent [5].”
BackgroundSelf-citationThe ambitious '95-95 by 2025' roadmap for the diagnosis and management of fungal diseases
Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207305 · Cited by 67 · cited 1×
“6 million deaths and contributing to the poor and fatal outcome of many more diseases [14].”
BackgroundSelf-citationBurden of serious fungal infections in Tanzania
Faini, D., Maokola, W., Furrer, H., Hatz, C., Battegay, M., Tanner, M., Denning, D. W., & Letang, E. (2015) · Mycoses · doi:10.1111/myc.12390 · Cited by 42
Self-citation
Cited by
Loyse, A., Burry, J., Cohn, J., Ford, N., Chiller, T., Ribeiro, I., Koulla-Shiro, S., Mghamba, J., Ramadhani, A., Nyirenda, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30493-6 · Cited by 90
Self-citationBastos, R. W., Valero, C., Silva, L. P., Schoen, T., Drott, M., Brauer, V., Silva-Rocha, R., Lind, A., Steenwyk, J. L., Rokas, A., et al. (2020) · mSphere · doi:10.1128/msphere.00153-20 · Cited by 60
Update on invasive fungal infections in the Middle Eastern and North African region
Osman, M., Al Bikai, A., Rafei, R., Mallat, H., Dabboussi, F., & Hamze, M. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00325-x · Cited by 39
Metadata
- Authors
- Tufa, T. B., & Denning, D. W.
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2019-11-22
- Volume
- 5
- Issue
- 4
- Pages
- 109
- ISSN
- 2309-608X (ISSN-L)
- OpenAlex
- W2989806003
- Cited by
- 45
- References
- 16
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.